Epilepsy drug useful for binge-eating disorder

	Tweet

The results of a small study published in the Journal of Clinical Psychiatry suggest that the epilepsy drug topiramate may provide long-term benefits for people with binge-eating disorder and obesity.

Dr. Susan L. McElroy, of the University of Cincinnati College of Medicine, Ohio, and colleagues studied 61 such subjects, who were randomly selected to take topiramate or an inactive “placebo”.

A total of 44 patients received at least one dose of topiramate, according to the report, and results were available for 43 who reached the final dose of 250 milligrams daily.

All 43 participants not only experienced a significant decline in the number of weekly binge episodes, but also saw a significant reduction in body weight.

Further studies of “topiramate in the long-term treatment of binge-eating disorder appear warranted,” the research team concludes.

SOURCE: Journal of Clinical Psychiatry, November 2004.

------------------------
PHENTERMINE ® is the #1 weight loss diet pill in the U.S. Phentermine helps suppress your appetite so that you can lose weight.
Order Phentermine Online
------------------------

RELATED STORIES:
Weight in pregnancy best controlled by diet, study shows   FDA advisers recommend approving weight loss drug   Bridal Hunger Games   Exercise, Group Support Work for Weight Loss   Misperception of weight is an important barrier to weight loss   Obesity drugs need heart studies, U.S. advisers say   Weight Loss Surgery and Diabetes: Expert Interview Opportunity   New evidence on effects of green coffee beans in weight loss   Chocolate lovers tend to weigh less: study   Weight loss won’t necessarily help teen girls’ self-esteem   How to Best Help Your Child Lose Weight: Lose Weight Yourself   Qnexa: Is the new anti-obesity drug too risky?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]